DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Junttila TT, Li J, Johnston J et al.
HER2 T cell dependent bispecific antibody (HER2-′TDB) for treatment of HER2 positive breast cancer. San Antonio Breast Cancer Symposium 2014; S1-07.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.